Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators planned to study the etiopathogenic factors of conotruncal cardiac defects regarding the relations between the metabolic, the genetic and the environmental factors which lead to these cardiopathy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects

NCT02378857

Congenital Heart Disease

COMPLETED

Fluid Balance in Children Undergoing Fontan Surgery

NCT02306057

Heart Defects, Congenital Hypoplastic Left Heart Syndrome

COMPLETED

Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation

NCT04151004

Patients

COMPLETED NA

Critical Congenital Heart Defect (CHD) Outcomes in Children

NCT00208689

Congenital Heart Disease

TERMINATED

Genetics of Congenital Heart Disease

NCT01192048

Congenital Heart Disease

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Conotruncal Cardiac Defects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conotruncal cardiac defects patients

Bood sampling for biochemicals and genetic analysis

Intervention Type BIOLOGICAL

There will be one blood sampling for the nutritionnal, metabolic and genetic parameters studied in the protocol

Mothers of patients

Bood sampling for biochemicals and genetic analysis

Intervention Type BIOLOGICAL

There will be one blood sampling for the nutritionnal, metabolic and genetic parameters studied in the protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bood sampling for biochemicals and genetic analysis

There will be one blood sampling for the nutritionnal, metabolic and genetic parameters studied in the protocol

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Conotruncal cardiac defects patients and theirs mothers
* Weight: \> 3750 g

Exclusion Criteria

* Syndromic conotruncal cardiac defects
* 22q11 deletion Holder's
* Patients whose mother's took anti-folates before and during first pregnancy semester

Minimum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes